TRAVERE THERAPEUTICS, INC.: accounts_receivable
| Value | {"amount": 14955000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2016-09-30) |
| Status | current |
| Entity | TRAVERE THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T14:10:32.965170+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/94622400-700a-4532-ad42-40c9d6f34c99
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001628280-16-020847Retrieved: 2026-08-19T14:10:32.965170+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001438533/accounts-receivable/2016-09-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/94622400-700a-4532-ad42-40c9d6f34c99
History
- no predecessors — first report